Vera Therapeutics drops 14% on upsized public offering of ~4.99M

• Vera Therapeutics (NASDAQ:VERA) prices its public offering of 4,993,067 shares at a price of $15.00 per share.
• Underwriters 30-day option to purchase up to an additional 748,959 shares.
• Gross proceeds are expected to be $74.9M. 
• Offering is expected to close on February 14, 2022.
• Stock drops 14% during pre-market.